tiprankstipranks
Trending News
More News >
LEPU ScienTech Medical Technology (Shanghai) Co., Ltd. Class H (HK:2291)
:2291
Hong Kong Market
Advertisement

LEPU ScienTech Medical Technology (Shanghai) Co., Ltd. Class H (2291) Dividend Date & History

Compare
1 Followers

Dividend Data

Last Ex-Dividend Date
May 26, 2025
Payment date​
Dividend Amount Per Share
HK$0.674
Annually
Dividend Yield
3.63%
Sector: Healthcare
Sector Average: 1.657%
Payout Ratio
74.65%
Dividend Growth​
a year ago
Since 2024
Last 3 Months

Dividend Amount Per Share​

2291 Dividend History

Ex-Date
Record Date
Payment Date
Frequency
Declaration Date
Amount
May 26, 2025
AnnuallyHK$0.67
May 28, 2024
AnnuallyHK$0.63
The table shows LEPU ScienTech Medical Technology (Shanghai) Co., Ltd. Class H’s dividend history, including amount per share, payout frequency, declaration, record, and payment dates.

FAQ

How much is LEPU ScienTech Medical Technology (Shanghai) Co., Ltd. Class H's dividend?
HK:2291 pays a dividend of HK$0.674 per share. HK:2291's annual dividend yield is 3.63%.
    When is LEPU ScienTech Medical Technology (Shanghai) Co., Ltd. Class H ex-dividend date?
    LEPU ScienTech Medical Technology (Shanghai) Co., Ltd. Class H (HK:2291) does not pay a dividend.
    When is LEPU ScienTech Medical Technology (Shanghai) Co., Ltd. Class H dividend payment date?
    LEPU ScienTech Medical Technology (Shanghai) Co., Ltd. Class H (HK:2291) does not pay a dividend.
    Does LEPU ScienTech Medical Technology (Shanghai) Co., Ltd. Class H have sufficient earnings to cover their dividend?
    Yes, HK:2291's past year earnings per share was HK$0.57, and their annual dividend per share is HK$0.67. HK:2291's dividend payout ratio is 74.65% (HK$0.67/HK$0.57) which is sustainable.
      What am I Missing?
      Make informed decisions based on Top Analysts' activity
      Know what industry insiders are buying
      Get actionable alerts from top Wall Street Analysts
      Find out before anyone else which stock is going to shoot up
      Get powerful stock screeners & detailed portfolio analysis